(PharmaNewsWire.Com, December 05, 2019 ) The increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research.
Market Size
The global Cell Surface Markers market size is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1%
Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Merck KGaA (Germany), and Bio-Techne (US) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.
“Thermo Fisher Scientific is one of the leading players in the cell surface markers market”
The company’s strong brand recognition and extensive product portfolio is its key strength. In order to maintain its leading position in this market, Thermo Fisher adopts organic and inorganic growth strategies such as acquisitions and expansions. For instance, in the last three years, the company acquired Affymetrix (US) and the Advanced Bioprocessing business from Becton, Dickinson and Company (US). Such acquisitions help Thermo Fisher in strengthening its Life Sciences Solutions segment for versatile product offerings. The company’s efforts towards enhancing its financial strategies have also significantly helped in sustaining its existing position within this market.
“Becton, Dickinson and Company (BD) is one of the prominent players in the cell surface markers market”
BD offers a robust product portfolio and has a strong geographical presence in this market. Its products are marketed internationally and in the US through independent distribution channels; they are also marketed directly to end users by the company itself, and also by independent sales representatives. The primary end users of the company’s products are hospitals, laboratories and clinics, blood banks, healthcare workers, public health agencies, academic and government institutions, and pharmaceutical and biotechnology companies.
We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
